Skip to main content

Traitement des tumeurs germinales de l’ovaire

  • Chapter
Les cancers ovariens

Part of the book series: Abord clinique ((ONCOLPRAT))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Talerman A (1995) Germ cell tumors of the ovary, in Kurman R (ed): Blaustein’s Pathology of the Female Genital Tract (ed 4). Springer-Verlag, New York, p 849–914

    Google Scholar 

  2. Norris HJ, Jensen RD (1972) Relative frequency of ovarian neoplasms in children and adolescents. Cancer 30: 713–9

    CAS  PubMed  Google Scholar 

  3. Tewari K, Cappuccini F, Disaia PJ et al. (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95: 128–33

    Article  CAS  PubMed  Google Scholar 

  4. Tangir J, Zelterman D, Ma W et al. (2003) Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 101: 251–57

    Article  PubMed  Google Scholar 

  5. International Federation of Gynecology and Obstetrics (1987) Change in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156: 236

    Google Scholar 

  6. Herrin VE, Thigpen JT (2000) Germ cell Tumors of Ovary. In: D. Raghavan, ML Brecher, DH Johnson, NJ Meropol, PL Moots, JT Thigpen, ed. in Textbook of uncommon cancer. J Wiley and Sons Ed, West Sussex, England, p 671–80

    Google Scholar 

  7. Culine S, Lhommé C, Kattan J et al. (1995). Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave-Roussy. Gynecol Oncol 58: 344–8

    Article  CAS  PubMed  Google Scholar 

  8. Williams SD, Gershenson DM, Horowitz CJ et al. (1997) Ovarian Germ-cell Tumors. In Principles and practice of Gynecologic Oncology, Hoskins WJ, Perez CA and Young RC, Lippincott-Raven ed, Philadelphia New-York, p 987–1001

    Google Scholar 

  9. Slayton RE, Park RC, Silverberg SG et al. (1985) Vincristine, dactinomycin and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group study (a final report). Cancer 56: 243–8

    CAS  PubMed  Google Scholar 

  10. Williams SD, Blessing JA, Liao SY et al. (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12: 701–6

    CAS  PubMed  Google Scholar 

  11. Williams SD, Blessing JA, Moore DH et al. (1989) Cisplatin, Vin-blastine and Bleomycin in advanced and recurrent ovarian germ cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 111: 22–7

    CAS  PubMed  Google Scholar 

  12. Culine S, Berton D, Rey A et al. (1996) Prognostic factors for survival in chemotherapy treated ovarian germ cell tumors. 32th Annual Meeting American Society of Clinical Oncology. Proc ASCO 15: 294

    Google Scholar 

  13. André F, Fizazi K, Culine S et al. (2000) The growing teratoma syndrome: results of therapy and long-term fol-low-up of 33 patients. Eur J Cancer 36: 1389–94

    Article  PubMed  Google Scholar 

  14. Low JJ, Perrin LC, Crandon AJ et al. (2000) Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 89: 391–8

    Article  CAS  PubMed  Google Scholar 

  15. Zanetta G, Bonazzi C, Cantu M et al. (2001) Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19: 1015–20

    CAS  PubMed  Google Scholar 

  16. Casey AC, Bhadauria S, Shapter A et al. (1996) Dysgerminoma: the role of conservative surgery. Gynecol Oncol 63: 352–7

    Article  CAS  PubMed  Google Scholar 

  17. Gershenson DM, Copeland IJ, Del Jungo G (1986) Second look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 67: 789–93

    CAS  PubMed  Google Scholar 

  18. Culine S, Lhommé C, Michel G et al. (1996) Is there a role for second look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave-Roussy. J Surg Oncol 62: 40–5

    Article  CAS  PubMed  Google Scholar 

  19. Gerbaulet a, Gandon C, Lusinchi A et al. (1988) Le séminome ovarien. Place de la radiothérapie. Expérience de l’institut Gustave-Roussy. Société franćaise de radiologie. J Eur Radiother 9: 134

    Google Scholar 

  20. De Palo G, Pilotti S, Kenda R et al. (1987) Germ cell tumors of the ovary: the experience of the National Cancer Insitute of Milan. I. Dysgerminoma. Int J Radiat Biol Phys 13: 853–60

    Google Scholar 

  21. Culine S, Lhommé C, Droz JP (1997). Traitement médical des tumeurs germinales malignes de l’ovaire de l’adulte. Bull Cancer 84: 919–21

    CAS  PubMed  Google Scholar 

  22. Culine S, Kattan J, Lhommé C et al. (1994) A phase II study of high-dose Cisplatin, Vinblastine, Bleomycin, and Etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol 54: 47–53

    Article  CAS  PubMed  Google Scholar 

  23. Culine S, Lhommé C, Kattan J et al. (1994) Long-term results of two VAB-like regimens (vinblastine + actinomycine-D + bléomycine + cyclophosphamide + cisplatine) in malignant germ cell tumours of the ovary. Eur J Cancer 30A: 1239–44

    CAS  PubMed  Google Scholar 

  24. Williams SD, Birch R, Einhorn LH et al. (1987) Disseminated germ cell tumors: chemotherapy with cisplatin, bleomycin plus either vinblastine or etoposide. N Engl J Med 316: 1434–40

    Google Scholar 

  25. Gershenson DM, Morris M, Cangir A (1990) Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 8: 715–20

    CAS  PubMed  Google Scholar 

  26. Williams SD, Kauderer J, Burnett AF et al. (2004) Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecol Oncol 95: 496–9

    Article  CAS  PubMed  Google Scholar 

  27. Gershenson DM (1988) Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6: 270–5

    CAS  PubMed  Google Scholar 

  28. Gershenson DM, Kavanagh JJ, Copeland LJ et al. (1986) Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatine. Cancer 57: 1731–7

    CAS  PubMed  Google Scholar 

  29. Segelov E, Campbell J, Ng M et al. (1994) Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12: 378–84

    CAS  PubMed  Google Scholar 

  30. Mayordomo JI, Paz-Ares L, Rivera F et al. (1994) Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patientes. Ann Oncol 5: 225–31

    CAS  PubMed  Google Scholar 

  31. Bower M, Fife K, Holden L et al. (1996) Chemotherapy for ovarian germ cell tumours. Eur J Cancer 32A: 593–7

    CAS  PubMed  Google Scholar 

  32. Mitchell PL, Al-Nasri N, A’Hern R et al. (1999) Treatment of nondysgerminomatous ovarian germ cell tumors. An analysis of 69 cases. Cancer 85: 2232–44

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Pautier, P., Lhommé, C. (2006). Traitement des tumeurs germinales de l’ovaire. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_36

Download citation

  • DOI: https://doi.org/10.1007/2-287-30921-7_36

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25168-9

  • Online ISBN: 978-2-287-30921-2

Publish with us

Policies and ethics